NMR STUDIES OF 15N, 13C LABELED RIBONUCLEOTIDES: HIV
15N、13C 标记核糖核苷酸的 NMR 研究:HIV
基本信息
- 批准号:6309040
- 负责人:
- 金额:$ 2.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-02-01 至 2002-01-14
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The SIR provided 13C15 N ASI cells; 20g
[U- "C, "N]AS 1 Cells; 50g The genome of HIV codes for two proteins,
Tat and Rev, which are essential regulators of transcription. Rev
binds to specific RNA sequence called the Rev Responsive Element
(RRE), which is found in the HIV genome and regulates the cytoplasmic
appearance of unspliced or singly spliced mRNAs which encode the
structural proteins gag, pol, and env. Rev has been proposed to have
a role both in regulation of splicing and in transport of the RNA to
the cytoplasm. Chemical and RNAse Protection experiments have shown
that a 66 nucleotide fragment, domain II of the RRE, is necessary and
sufficient for high affinity binding of Rev in in vitro and that
domain H alone is sufficient for a detectable Rev responsiveness in
vivo. The core Rev binding element within the RRE and the critical
bases or base-base interactions have recently been more precisely
defined by an interactive in vitro genetic selection as well as other
techniques. RNA oligonucleotides 30-35 nucleotides long containing
the core binding element were shown to bind Rev with wild type
affinity. Other studies have shown that a 17 amino acid arginine rich
peptide from Rev binds RRE at multiple sites and specifically inhibits
splicing in vitro. A single peptide specifically binds in the core
element of the RRE. We propose the us multidimensional, multinuclear
NMR spectroscopy to elucidate the structural features of the RRE that
are important in REV recognition and binding. 13C and 15N labeled
samples of RNA synthesized using labeled NTPs isolated from the RNA of
methanolotrophic bacterial. These labeled samples will be used in NMR
studies of the structure of RNA and RNA-Rev peptide complexes.
Various derivatives of the consensus RNA sequence will also be studied
in order to further define the structural requirements for Rev.
SIR提供13 C15 N ASI细胞; 20 g
[U-“C,“N]AS 1细胞; 50 g HIV的基因组编码两种蛋白质,
达特和Rev,它们是转录的基本调节因子。 Rev
与称为Rev反应元件的特定RNA序列结合
(RRE),它存在于HIV基因组中,调节细胞质中的
未剪接或单剪接的mRNA的出现,
结构蛋白gag、pol和env。 已建议Rev
在剪接的调节和RNA的运输中起作用,
细胞质 化学和RNA酶保护实验表明,
一个66个核苷酸的片段,RRE的结构域II,是必需的,
足以在体外高亲和力结合Rev,
单独的结构域H足以在细胞中产生可检测的Rev响应性。
vivo. RRE中的核心Rev约束元素和关键
碱基或碱基间的相互作用最近被更精确地
通过交互式体外遗传选择以及其他
技术. RNA寡核苷酸30-35个核苷酸长,含有
核心结合元件显示与野生型Rev结合
亲和力 其他研究表明,富含17个氨基酸的精氨酸
来自Rev的肽在多个位点结合RRE,并特异性抑制
体外剪接。 一个单一的肽特异性地结合在核心
RRE的元素。 我们建议美国多层面,多核
NMR光谱以阐明RRE的结构特征,
在REV识别和绑定中很重要。 13 C和15 N标记
使用分离自以下的RNA的标记的NTP合成的RNA样品:
产甲烷细菌 这些标记的样品将用于NMR
RNA和RNA-Rev肽复合物的结构研究。
各种衍生物的共识RNA序列也将进行研究
为进一步明确Rev.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JULI FEIGON其他文献
JULI FEIGON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JULI FEIGON', 18)}}的其他基金
Structural biology of 7SK RNP and its interaction with HIV-1 Tat
7SK RNP 的结构生物学及其与 HIV-1 Tat 的相互作用
- 批准号:
10170271 - 财政年份:2020
- 资助金额:
$ 2.74万 - 项目类别:
Structural biology of 7SK RNP and its interaction with HIV-1 Tat
7SK RNP 的结构生物学及其与 HIV-1 Tat 的相互作用
- 批准号:
10402809 - 财政年份:2020
- 资助金额:
$ 2.74万 - 项目类别:
Structural biology of 7SK RNP and its interaction with HIV-1 Tat
7SK RNP 的结构生物学及其与 HIV-1 Tat 的相互作用
- 批准号:
10082693 - 财政年份:2020
- 资助金额:
$ 2.74万 - 项目类别:
相似海外基金
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10448926 - 财政年份:2021
- 资助金额:
$ 2.74万 - 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10491861 - 财政年份:2021
- 资助金额:
$ 2.74万 - 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10675535 - 财政年份:2021
- 资助金额:
$ 2.74万 - 项目类别:
EPSRC Centre for Doctoral Training in Bioprocess Engineering Leadership (Complex Biological Products Manufacture)
EPSRC 生物过程工程领导力博士培训中心(复杂生物制品制造)
- 批准号:
EP/S021868/1 - 财政年份:2019
- 资助金额:
$ 2.74万 - 项目类别:
Training Grant
Exploring interactions and benefits of novel microbial biological products in blueberry propagation
探索新型微生物生物制品在蓝莓繁殖中的相互作用和益处
- 批准号:
529840-2018 - 财政年份:2018
- 资助金额:
$ 2.74万 - 项目类别:
Applied Research and Development Grants - Level 1
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
- 批准号:
1403724 - 财政年份:2014
- 资助金额:
$ 2.74万 - 项目类别:
Standard Grant
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
- 批准号:
1403697 - 财政年份:2014
- 资助金额:
$ 2.74万 - 项目类别:
Standard Grant
Formulation and delivery approaches for water soluble biological products delivered through the skin focussing on L-Ascorbic Acid.
通过皮肤输送的水溶性生物产品的配方和输送方法,重点是 L-抗坏血酸。
- 批准号:
131690 - 财政年份:2014
- 资助金额:
$ 2.74万 - 项目类别:
Feasibility Studies
Formulation and stability of biological products for skin delivery focussing on Retinol.
以视黄醇为重点的皮肤输送生物制品的配方和稳定性。
- 批准号:
131338 - 财政年份:2013
- 资助金额:
$ 2.74万 - 项目类别:
Feasibility Studies
Demonstrate the effectiveness of antimicrobial protection of new types of Biological Products
展示新型生物制品抗菌保护的有效性
- 批准号:
429734-2011 - 财政年份:2012
- 资助金额:
$ 2.74万 - 项目类别:
Experience Awards (previously Industrial Undergraduate Student Research Awards)